Bile Duct Cancer: Research
The question
To ask the Secretary of State for Health and Social Care, what funding has been allocated by (a) his Department, (b) the National Institute for Health and Care Research and (c) other publicly funded bodies for research into cholangiocarcinoma in each of the last five years; and whether he plans to increase support for research into the early diagnosis and treatment of that disease.
Answered by Preet Kaur Gill
Government responsibility for delivering cancer research is shared between Department for Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation (UKRI).
The Department of Health and Social Care’s investment in the NIHR facilitates the direct funding of research projects through NIHR programmes, support for researchers to develop and conduct research through NIHR translational infrastructure, and a workforce to deliver research on behalf of other funders through NIHR research delivery infrastructure.
Between the financial years 2020/21 and 2024/25, through the NIHR, the Department committed £6.8 million for new research projects alongside supporting infrastructure into cholangiocarcinoma. This includes committing over £2.6 million in financial year 2024/25 alone. The following table shows the breakdown by financial year of this research funding:
Financial year | NIHR (millions) |
2020/21 | £1.1 |
2021/22 | £1.0 |
2022/23 | £1.1 |
2023/24 | £1.0 |
2024/25 | £2.6 |
Total | £6.8 |
The Department does not hold information on research funding for cholangiocarcinoma allocated through other public bodies.
The NIHR continues to welcome high quality applications for research into any aspect of human health and care, including the early diagnosis and treatment of cholangiocarcinoma. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to the public and health and care services, value for money, and scientific quality.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →